Delivra Health Brands Stock Performance
| DHBUF Stock | USD 0.13 0.09 211.00% |
Delivra Health holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -12.86, which means a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Delivra Health are expected to decrease by larger amounts. On the other hand, during market turmoil, Delivra Health is expected to outperform it. Use Delivra Health total risk alpha, expected short fall, period momentum indicator, as well as the relationship between the value at risk and rate of daily change , to analyze future returns on Delivra Health.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Delivra Health Brands are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Delivra Health reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 4.4 M | |
| Total Cashflows From Investing Activities | 1.4 M |
Delivra |
Delivra Health Relative Risk vs. Return Landscape
If you would invest 11.00 in Delivra Health Brands on December 23, 2024 and sell it today you would earn a total of 2.00 from holding Delivra Health Brands or generate 18.18% return on investment over 90 days. Delivra Health Brands is currently producing 6.8165% returns and takes up 51.9853% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Delivra, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Delivra Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Delivra Health's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Delivra Health Brands, and traders can use it to determine the average amount a Delivra Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1311
| Best Portfolio | Best Equity | DHBUF | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 51.99 actual daily | 96 96% of assets are less volatile |
Expected Return
| 4.96 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.13 actual daily | 10 90% of assets perform better |
Based on monthly moving average Delivra Health is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Delivra Health by adding it to a well-diversified portfolio.
Delivra Health Fundamentals Growth
Delivra OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Delivra Health, and Delivra Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Delivra OTC Stock performance.
| Return On Equity | -1.01 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (0.77) % | |||
| Operating Margin | (0.66) % | |||
| Current Valuation | 4.15 M | |||
| Shares Outstanding | 252.62 M | |||
| Price To Book | 1.66 X | |||
| Price To Sales | 0.48 X | |||
| Revenue | 8.14 M | |||
| EBITDA | (4.25 M) | |||
| Cash And Equivalents | 1.67 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.67 M | |||
| Debt To Equity | 0.38 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (4.44 M) | |||
| Total Asset | 11.59 M | |||
About Delivra Health Performance
By analyzing Delivra Health's fundamental ratios, stakeholders can gain valuable insights into Delivra Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Delivra Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Delivra Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada. Delivra Health is traded on OTC Exchange in the United States.Things to note about Delivra Health Brands performance evaluation
Checking the ongoing alerts about Delivra Health for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Delivra Health Brands help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Delivra Health is way too risky over 90 days horizon | |
| Delivra Health has some characteristics of a very speculative penny stock | |
| Delivra Health appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 8.14 M. Net Loss for the year was (7.01 M) with profit before overhead, payroll, taxes, and interest of 2.6 M. | |
| Delivra Health Brands has accumulated about 1.67 M in cash with (4.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 22.0% of the company shares are held by company insiders |
- Analyzing Delivra Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Delivra Health's stock is overvalued or undervalued compared to its peers.
- Examining Delivra Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Delivra Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Delivra Health's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Delivra Health's otc stock. These opinions can provide insight into Delivra Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Delivra OTC Stock analysis
When running Delivra Health's price analysis, check to measure Delivra Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Delivra Health is operating at the current time. Most of Delivra Health's value examination focuses on studying past and present price action to predict the probability of Delivra Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Delivra Health's price. Additionally, you may evaluate how the addition of Delivra Health to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |